| |
Clinical model FPR 10%
|
Clonal model FPR 10%
|
Concordance between clinical and clonal modelsa
|
|---|
|
R5
|
X4
|
R5/X4
|
p-value*
|
R5
|
X4
|
R5/X4
|
p-value*
|
R5-R5
|
R5-X4
|
X4-R5
|
X4-X4
|
p-value**
|
|---|
|
Number (%)
|
285 (81)
|
60 (17)
|
7 (2)
| |
291 (82.7)
|
50 (14.2)
|
11 (3.1)
| |
245 (69.6)
|
40 (11.4)
|
46 (13.0)
|
21 (6.0)
| |
|
CD4 cells/ul median (IQR)
|
132 (76–193)
|
41 (21–98)
|
130 (107–220)
|
<0.001
|
125 (67–189)
|
89 (42–140)
|
160 (72–177)
|
0.08
|
135 (77–196)
|
127 (74–188)
|
55 (21–128)
|
70 (22–91)
|
<0.001
|
|
VL median (IQR)
|
5.3 (4.8–5.8)
|
5.4 (5.1–5.8)
|
5.3 (4.4–5.7)
|
0.18
|
5.4 (4.9–5.8)
|
5.4 (5–5.9)
|
5.4 (4.7–5.7
|
0.50
|
5.3 (4.8–5.8)
|
5.4 (5.1–5.9)
|
5.3 (4.4–5.7)
|
5.8 (5.3–5.9)
|
0.170
|
- *Mann-Whitney U-Test; **Kruskal Wallis Test; aR5-R5: both models predicted R5 virus; R5-X4: clinical model predicted R5 virus and clonal model predicted X4 virus; X4-R5: clinical model predicted X4 virus and clonal model predicted R5 virus; X4-X4: both models predicted X4 virus. VL: viral load (copies/ml)
